A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

395

Participants

Timeline

Start Date

November 6, 2018

Primary Completion Date

May 7, 2024

Study Completion Date

January 9, 2026

Conditions
Multiple Myeloma
Interventions
DRUG

Daratumumab

Daratumumab (1800 mg) will be administered by SC injection once every week for Cycles 1 to 2, then every 3 weeks for Cycles 3-8. For Cycle 9 and beyond, participants will receive daratumumab 1800 mg SC once every 4 weeks until documented disease progression or unacceptable toxicity.

DRUG

Bortezomib

Bortezomib 1.3 mg/m\^2 will be administered by SC injection twice weekly on Days 1, 4, 8, and 11 of each 21-day cycle for Cycles 1-8.

DRUG

Lenalidomide

Lenalidomide will be self-administered at a dose of 25 mg orally on Day 1 to Day 14 for Cycles 1 through 8 and on Days 1 to 21 for Cycle 9 and beyond until disease progression or unacceptable toxicity whichever occurs first.

DRUG

Dexamethasone

Dexamethasone will be self-administered orally, 20 mg on Days 1, 2, 4, 5, 8, 9, 11, 12 of each 21-day cycle for Cycles 1-8. During Cycle 9 and beyond dexamethasone, will be self-administered orally at a total dose of 40 mg on Days 1, 8, 15, 22 of each 28-day cycle.

Trial Locations (114)

4103

Universitatsmedizin Leipzig, Leipzig

11501

NYU Winthrop, Mineola

13009

Institut Paoli Calmettes, Marseille

14263

Roswell Park Cancer Institute, Buffalo

19002

Hosp. Univ. de Guadalajara, Guadalajara

20090

Centrum Onkologii Ziemi Lubelskiej im sw Jana z Dukli, Lublin

22908

University of Virginia, Charlottesville

28204

Levine Cancer Institute, Charlotte

28222

Hosp. Univ. Pta. de Hierro Majadahonda, Majadahonda

28223

Hosp. Quiron Madrid Pozuelo, Pozuelo de Alarcón

28922

Hosp. Univ. Fundacion Alcorcon, Alcorcón

29303

Gibbs Cancer Center, Spartanburg

31059

Institut Universitaire du cancer de Toulouse-Oncopole, Toulouse

32207

Baptist MD Anderson, Jacksonville

33604

CHU de Bordeaux - Hospital Haut-Leveque, Pessac

34093

Istanbul University Istanbul Medical Faculty, Istanbul

34295

CHU de Montpellier Hopital Saint Eloi, Montpellier

35340

Dokuz Eylul University Medical Faculty, Izmir

38100

Hillel Yaffe Medical Center, Hadera

40207

Norton Healthcare, Louisville

44195

Cleveland Clinic, Cleveland

44281

Meir Hospital, Kfar Saba

46804

Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne

49100

Rabin Medical Center, Petah Tikva

49503

Cancer And Hematology Centers of Western Michigan PC, Grand Rapids

52621

Sheba Medical Center, Ramat Gan

55280

Ondokuz Mayis University, Samsun

56068

Institut für Versorgungsforschung, Koblenz

59037

Hopital Claude Huriez, Lille

59075

St. Josef-Krankenhaus Hamm-Bockum-Hövel, Hamm

63739

phase 3 - Hämatoonkologischer Studienkreis am Klinikum Aschaffenburg, Aschaffenburg

64111

Saint Lukes Hospital Saint Lukes Cancer Specialists, Kansas City

64239

Sourasky (Ichilov) Medical Center, Tel Aviv

67000

Strasbourg Oncologie Libérale, Strasbourg

72076

Universitaetsklinikum Tuebingen der Eberhard-Karls-Universitaet, Abteilung fuer Innere Medizin II,, Tübingen

77030

University of Texas, MD Anderson Cancer Center, Houston

78741

Barzilai Medical Center, Ashkelon

79106

Universitatsklinikum Freiburg, Freiburg im Breisgau

81377

Klinikum Großhadern der Ludwig-Maximilians-Universität, München

85925

Centre Hospitalier Départmental La Roche sur Yon, La Roche-sur-Yon

87401

San Juan Oncology Associates, Farmington

90703

Innovative Clinical Research Inc, Cerritos

94010

CHU Henri Mondor, Créteil

97330

Good Samaritan Hospital Corvallis, Corvallis

3109601

Rambam Med.Center - Hematology Institute, Haifa

3436212

Carmel Medical Center, Haifa

02111

Tufts Medical Center, Boston

02118

Boston University Medical Center, Boston

08901

Rutgers Cancer Institute of New Jersey, New Brunswick

15232 1301

University Of Pittsburgh Medical Center UPMC Hillman Cancer Center, Pittsburgh

13083-878

Universidade Estadual De Campinas, Campinas

59062 000

Liga Norte Riograndense Contra O Cancer, Natal

90610-000

Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da PUCRS, Porto Alegre

20230-130

Ministerio da Saude Instituto Nacional do Cancer, Rio de Janeiro

22775 001

Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI), Rio de Janeiro

01227-200

Instituto de Ensino e Pesquisa São Lucas, São Paulo

01323 900

Real e Benemerita Associacao Portuguesa de Beneficencia, São Paulo

03102-002

Instituto Brasileiro de Controle do Cancer - Sao Camilo Oncologia, São Paulo

04122-000

Hospital Santa Cruz, São Paulo

04537-081

Clinica Medica Sao Germano S/S LTDA, São Paulo

T2N 5G2

Arthur J E Child Comprehensive Cancer Centre, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

V5Z 1M9

The Gordon & Leslie Diamond Health Care Center, Vancouver

B3H 1V7

QEII Health Sciences Centre, Halifax

L6R 3J7

Brampton Civic Hospital, Brampton

N6A 5W9

Victoria Hospital, London

L1G-2B9

Lakeridge Health Oshawa, Oshawa

H4A 3J1

McGill University Health Centre, Montreal

G1J 1Z4

CHU de Quebec L Hotel Dieu de Quebec, Québec

625 00

Fakultni nemocnice Brno, Brno

500 05

Fakultni nemocnice Hradec Kralove, Hradec Králové

708 52

Fakultni Nemocnice Ostrava, Ostrava

323 00

Fakultni nemocnice Plzen, Hemato-onkologicke oddeleni, Pilsen

128 08

Vseobecna fakultni nemocnice v Praze, Prague

814-0180

Fukuoka University Hospital, Fukuoka

503-8502

Ogaki Municipal Hospital, Gifu

920 8641

Kanazawa University Hospital, Kanazawa

650 0047

Kobe City Medical Center General Hospital, Kobe

860-0008

National Hospital Organization Kumamoto Medical Center, Kumamoto

602-8566

University Hospital Kyoto Prefectural University of Medicine, Kyoto

399-8701

National Hospital Organization Matsumoto Medical Center, Matsumoto

790-8524

Matsuyama Red Cross Hospital, Matsuyama

467 8602

Nagoya City University Hospital, Nagoya

701-1192

National Hospital Organization Okayama Medical Center, Okayama

543 8555

Japanese Red Cross Osaka Hospital, Osaka

377-0280

National Hospital Organization Shibukawa Medical Center, Shibukawa

150-8935

Japanese Red Cross Medical Center, Shibuya City

1081 HV

VU Medisch Centrum, Amsterdam

3318 AT

Albert Schweitzer ziekenhuis-lokatie Dordwijk, Dordrecht

3015CE

Erasmus MC, Rotterdam

36-200

Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im Ks B Markiewicza, Brzozów

41-500

Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespol Szpitali Miejskich, Chorzów

80 214

Uniwersyteckie Centrum Kliniczne, Gdansk

25 734

Swietokrzyskie Centrum Onkologii SPZOZ w Kielcach, Kielce

30 688

NSSU Szpital Uniwersytecki w Krakowie, Krakow

60-569

Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan

76-200

Wojewodzki Szpital Specjalistyczny im. Janusza Korczaka, Słupsk

02 776

Instytut Hematologii i Transfuzjologii, Warsaw

02-781

Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy, Warsaw

08003

Hosp. Del Mar, Barcelona

08221

Hosp. Mutua Terrassa, Terrassa

06010

Gulhane Egitim ve Arastirma Hastanesi, Ankara

06100

Hacettepe University Medical Faculty, Ankara

06200

Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara

06590

Ankara University School of Medicine Cebeci Hospital, Ankara

ML6 0JS

Monklands District General Hospital, Airdrie

FY3 8NR

Blackpool Victoria Hospital, Blackpool

CF14 4XN

University Hospital Wales, Cardiff

CO4 5JL

Colchester Hospital University NHS, Colchester

LE1 5WW

Leicester Royal Infirmary - Haematology, Leicester

BT47 6SB

Altnagelvin Hospital, Londonderry

OL1 2JH

The Royal Oldham Hospital, Oldham

PL6 8DH

Derriford Hospital, Plymouth

WV10 0QP

New Cross Hospital, Wolverhampton

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY